Behind the Byline: What Journalists Look for When Covering Biotech
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
-
Narrated by:
-
By:
In this episode of The Russo Edge, two leading journalists pull back the curtain on how science becomes a headline. Heather McKenzie, Senior Editor at BioSpace and Ben Glickman, Reporter at The Wall Street Journal, join host Solomon Wilcots to share what earns their attention, what builds trust, and what turns them off before a single question is asked.
Together, they break down how biotech companies can communicate complex data with clarity, why timing is everything when engaging in the press, and how credibility can be strengthened long before a major announcement. From background conversations to clear trial summaries and investor context, this conversation offers practical, real-world advice for biotech leaders.
No reviews yet